Oxidative stress in carcinogenesis: New synthetic compounds with dual effects upon free radicals and cancer

Current Medicinal Chemistry

Volumn 20, Issue 36, 2013, Pages 4451-4459

  Tekiner Gulbas, Betul ^a   Westwell, Andrew D ^b   Suzen, Sibel ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anticancer; Antioxidant; Carcinogenesis; DNA mutation; Drug development; Oxidative stress

Indexed keywords

2 IMINEINDOLE; 3 IMINEINDOLE; 7 IMINEINDOLE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BARBITAL; BENZENESULFONAMIDE DERIVATIVE; CATALASE; CHROMONE DERIVATIVE; CISPLATIN DERIVATIVE; COPPER COMPLEX; COUMARIN DERIVATIVE; DEHYDROTARPLATIN; FLAVONOID; FREE RADICAL; GLUTATHIONE REDUCTASE; HYDRAZONE DERIVATIVE; HYDROXYL RADICAL; INDOLEAMINE; INDOLEPROPIONIC ACID; ISATIN; MECLOFENAMIC ACID; MELATONIN; METAL COMPLEX; PEROXY RADICAL; POLYPHENOL DERIVATIVE; PYRIDINE DERIVATIVE; RESVERATROL; RUTHENIUM COMPLEX; TRIACID; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CARCINOGENESIS; DEGENERATIVE DISEASE; DNA CLEAVAGE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; HUMAN; IC 50; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARCINOGENESIS; DNA; DNA MUTATIONAL ANALYSIS; FREE RADICALS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84887940292     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113203690142     Document Type: Article

References (91)

1. Valko, M.; Rhodes, C.J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 2006, 160, 1-40.
2. Cooke, M.S.; Evans, M.D.; Dizardaroglu, M.; Lunec, J. Oxidative DNA damage: mechanisms, mutation and disease. FASEB J., 2003, 17, 1195-1214
3. Dizardaroglu, M., Kirkali, G.; Jaruge, P. Formamidopyrimidines in DNA: mechanisms of formation, repair, and biological effects. Free Radic. Biol. Med., 2008, 45, 1610-1621
4. Dizdaroglu, M.; Jaruga, P.; Birincioglu, M.; Rodriguez, H. Free radical-induced damage to DNA: mechanisms and measurement. Free Rad. Biol. Med., 2002, 32, 1102-1115.
5. Stadtman, E.R. Protein oxidation and aging. Science, 1992, 257, 1220-1224.
6. Penta, J.S.; Johnson, F.M.; Wachsman, J.T.; Copeland, W.C. Mitochondrial DNA in human malignancy. Mutat. Res.-Rev. Mutat. Res., 2001, 488, 119-133.
7. Marnette, L.J. Oxyradicals and DNA damage. Carcinognesis, 2000, 21, 361-370
8. Arikan, S.; Akcay, T.;, Konukoglu, D.; Obek, C.; Kural, A.R. The relationship between antioxidant enzymes and bladder cancer. Neoplasia, 2005, 52, 314-7.
9. Kaynar, H.; Meral, M.; Turhan, H.; Keles, M.; Celik, G.; Akcay, F. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett., 2005, 227, 133-9.
10. Yalçin, O.; Karata, F.; Erula, F.A.; Ozdemir, E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int., 2004, 93, 863-6.
11. Jimenez-Del-Rio, M.; Velez-Pardo, C. The bad, the good, and the ugly about oxidative stress. Oxid. Med. Cell Longev., 2012, 2012, 1-13.
12. Dayem, A.A., Choi, H.Y.; Kim, J.H.; Cho, S.G. Role of oxidative stress in stem, cancer, and cancer stem cells. Cancers, 2010, 2, 859-884
13. Poli, G.; Biasi, F.; Chiarpotto, E. Oxidative stress and cell signaling. Curr. Med. Chem. 2004, 11, 1163-1182.
14. Parke, D.V. Chemical toxicity and reactive oxygen species. Int. J. Occup. Med. Environ. Health 1996, 9, 331-340.
15. Waris, G.; Ahsan, H. Reactive oxygen species: Role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5, 1-8.
16. Klaunig, J.E.; Kamendulis, L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 2004, 44, 239-267
17. Benhar, M.; Engelberg, D.; Levitzki, A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep., 2002, 3, 420-425
18. Klaunig, J.E.; Wang, Z.; Pu, X.; Zhou, S. Oxidative stress and oxidative damage in chemical carcinogenesis.Toxicol. Appl. Pharmacol., 2011, 254, 86-99.
19. Rice-Evans, C.A. Flavonoid antioxidants. Curr. Med. Chem., 2001, 8, 797-807.
20. Khobragade, C.N.; Bodade, R.G.; Shinde, M.S.; Jaju, D.; Bhosle, R.B.; Dawane, B.S. Microbial and xanthine dehydrogenase inhibitory activity of some flavones. J. Enzyme Inhib. Med. Chem., 2008, 23, 341-6.
21. Leu, Y.I.; Ho, D.K.; Cassady, J.M.; Cook, V.M.; Barid, W.M. Isolation of potential cancer chemopreventive agents from Eriodictyon californicum. J. Nat. Prod., 1992, 55, 357-63.
22. Gee, J.M.; Johnson, I.T. Polyphenolic compounds: interactions with the gut and implications for human health. Curr. Med. Chem., 2001, 8, 1245-55.
23. Kamal, A.; Murty, J.N.; Viswanath, A.; Sujitha, P.; Ganesh, K.C. Synthesis, biological evaluation of 5-carbomethoxymethyl-7-hydroxy-2- pentylchromone, 5-carboethoxymethyl-4',7-dihydroxyflavone and their analogues. Bioorg. Med. Chem. Lett., 2012, 22, 4891-5.
24. Kandaswami ,C.; Lee, L.T.; Lee, P.P.; Hwang, J.J.; Ke, F.C.; Huang, Y.T.; Lee, M.T. The antitumor activities of flavonoids. In vivo, 2005, 19, 895-909.
25. Le Marchand, L. Cancer preventive effects of flavonoids-A review. Biomed. Pharmacother., 2002, 56, 296-301.
26. Lahiri-Chatterjee, M.; Katiyar, S.K.; Mohan, R.R.; Agarwal R. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res., 1999, 59, 622-632.
27. Tsyrlov, I.B.; Mikhailenko, V.M.; Gelboin, H.V. Isozyme-and species-specific susceptibility of cDNA expressed CYP1A P-450s to different flavonoids. Biochim. Biophys. Acta, 1994, 1205, 325-335.
28. Pouget, C.; Lauthier, F.; Simon, A.; Fagnere, C.; Basly, J.P.; Delage, C.; Chulia, A.J. Flavonoids: Structural requirements for antiproliferative activity on breast cancer cells. Bioorg. Med. Chem. Lett., 2001, 11, 3095-3097.
29. Chan, W.S.; Wen, P.C.; Chiang, H.C. Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition. Anticancer Res., 1995, 15, 703-707.
30. Mutoh, M.; Takahashi, M.; Fukuda, K.; Komatsu, H.; Enya, T.; Matsushima-Hibiya, Y.; Mutoh, H.; Sugimura, T.; Wakabayashi, K. Suppression by flavonoids of cyclooxygenase-2 promoterdependent transcriptional activity in colon cancer cells: Structureactivity relationship. Jpn. J. Cancer Res., 2000, 91, 686-691.
31. Wang, W.; Goodman, M.T. Antioxidant property of dietary phenolic agents in a human LDL-oxidation ex vivo model: Interaction of protein binding activity. Nutr. Res., 1999, 19, 191-202.
32. Ren, W.; Qiao, Z.; Wang, H.; Zhu, L.; Zhang, L. Flavonoids: promising anticanceragents. Med. Res. Rev., 2003, 23, 519-534.
33. Rajesh, G.; Harshala, S.; Dhananjay, G.; Jadhav, A.; Vikram, G. Effect of hydroxyl substitution of flavone on angiogenesis and free radical scavenging activities: a structure-activity relationship studies using computational tools. Eur. J. Pharm. Sci., 2010, 39, 37-44.
34. Jia, Z.S.; Zhou, B.; Yang, L.; Wu, L.M.; Liu, Z.L. Antioxidant synergism of tea polyphenols and-tocopherol against free radical induced peroxidation of linoleic acid in solution. J. Chem. Soc., Perkin Trans. 1998, 2, 911-916
35. Stefano M.; Maria C.A.; Francesco C.; Alessandro C.; Caterina V.; Antonio T. Synthesis and "double-faced" antioxidant activity of polyhydroxylated 4-thiaflavans. Org. Biomol. Chem., 2005, 3, 3066-72
36. Darvesh, A.S.; Carroll, R.T.; Bishayee, A.; Geldenhuys, W.J.; Van Der Schyf, C.J. Oxidative stress and lzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev. Neurother., 2010, 10, 729-745.
37. Ghosh, N.; Ghosh, R.; Mandal, S.C. Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease. Free Rad. Res., 2011, 45, 888-905.
38. Hu, M.L. Dietary polyphenols as antioxidants and anticancer agents: more questions than answers. Chang Gung Med. J., 2011, 34, 449-60.
39. Dong, Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat. Res., 2003, 523-524, 145-150.
40. Cai, Y.J.; Fang, J.G.; Ma, L.P.; Yang, L.; Liu, Z.L. Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochim. Biophys. Acta., 2003, 1637, 31-38.
41. Murias, M.; Jager, W.; Handler, N.; Erker, T.; Horvath, Z.; Szekeres, T.; Nohl, H.; Gille, L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol., 2005, 69, 903-912.
42. Ding, D.J.; Cao, X.Y.; Dai, F.; Li, X.Z.; Liu. G.Y.; Lin, D.; Fu, X.; Jin, X.L.; Zhou, B. Synthesis and antioxidant activity of hydroxylated phenanthrenes as cis-restricted resveratrol analogues. Food Chem., 2012, 135, 1011-9.
43. Cai, Y.J.; Wei, Q.Y.; Fang, J.G.; Yang, L.; Liu, Z.L.; Wyche, J.H.; Han, Z. The 3,4-dihydroxyl groups are important for transresveratrol analogs to exhibit enhanced antioxidant and apoptotic activities.Anticancer Res., 2004, 24, 999-1002.
44. Du, K.J.; Wang, J.Q.; Kou, J.F.; Li, G.Y.; Wang, L.L.; Chao, H.; Ji, L.N. Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes. Eur. J. Med. Chem., 2011, 46, 1056-1065.
45. Xu, L.; Zhong, N.J.; Huang, H.L.; Liang, Z.H.; Li, Z.Z.; Liu, Y.J. Synthesis, characterization, cellular uptake, apoptosis, cytotoxicity, DNA-binding, and antioxidant activity studies of ruthenium(II) complexes. Nucleosides Nucleotides Nucleic Acids, 2012, 31, 575-91.
46. Liu, Y.J.; Zeng, C.H.; Liang, Z.H.; Yao, J.H.; Huang, H.L.; Li, Z.Z.; Wu, F.H. Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity. Eur. J. Med. Chem., 2010, 45, 3087-95.
47. Dhara, K.; Ratha, J.; Manassero, M.; Wang, X.Y.; Gao, S.; Banerjee, P. Synthesis, crystal structure, magnetic property and oxidative DNA cleavage activity of an octanuclear copper(II) complex showing water-perchlorate helical network. J. Inorg. Biochem., 2007, 101, 95-103.
48. Nannelli, A.; Messina, A.; Marini, S.; Trasciatti, S.; Longo, V.; Gervasi, P.G. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues. Arch. Toxicol., 2007, 81, 479-87.
49. Raja, D.S.; Bhuvanesh, N.S.; Natarajan, K. A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3- carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity. Dalton Trans., 2012, 41, 4365-77.
50. Raja, D.S.; Bhuvanesh, N.S.; Natarajan, K. Effect of N(4)-phenyl substitution in 2-oxo-1,2-dihydroquinoline-3-carbaldehyde semicarbazones on the structure, DNA/protein interaction, and antioxidative and cytotoxic activity of Cu(II) complexes. Inorg. Chem., 2011, 50, 12852-66.
51. Kovala-Demertzi, D.; Hadjipavlou-Litina, D.; Staninska, M.; Primikiri, A.; Kotoglou, C.; Demertzis, M.A. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt( II), nickel(II), copper(II) and zinc(II). J. Enzyme Inhib. Med. Chem., 2009, 24, 742-52.
52. Kovala-Demertzi, D.; Staninska, M.; Garcia-Santos, I.; Castineiras, A.; Demertzis, M.A. Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity. J. Inorg. Biochem., 2011, 105, 1187-95.
53. Dokorou, V.; Primikiri, A.; Kovala-Demertzi, D. The triphenyltin( VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents. J. Inorg. Biochem., 2011, 105, 195-201.
54. Suzen, S. Topics in heterocyclic chemistry, bioactive heterocycles v, chapter: antioxidant activities of synthetic indole derivatives and possible activity mechanisms, Khan, M.T.H. (Ed.), Spinger-Verlag Berlin Heidelberg, 2007; 11:145-178.
55. Suzen, S. Recent developments of melatonin related antioxidant compounds. Com. Chem. High T. Synt., 2006, 9, 409-419.
56. Hossain, M.; Shaha, S.K.; Aziz, F. Antioxidant potential study of some synthesized N-heterocycles. Bangladesh Med. Res. Counc. Bull., 2009, 35, 49-52.
57. Tan, D.X.; Reiter, R.J., Manchester, L.C.; Yan, M.T.; El-Sawi, M.; Sainz, R.M.; Mayo, J.C.; Kohen, R.; Allegra, M.; Hardeland, R. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem., 2002, 2, 181-97.
58. Cano, A.; Alcaraz, O.; Arnao, M.B. Free radical-scavenging activity of indolic compounds in aqueous and ethanolic media. Anal. Bioanal. Chem., 2003, 376, 33-37.
59. Andreadou, I.; Tsantili-Kakoulidou, A.; Spyropoulou, E.; Siatra, T. Reactions of Indole Derivatives with Cardioprotective Activity with Reactive Oxygen Species. Comparison with Melatonin. Chem. Pharm. Bull., 2003, 51, 1128-1131.
60. Misik, V.; Ondrias, K.; Stasko, A. EPR spectroscopy of free radical intermediates of antiarrhythmic-antihypoxic drug stobadine, a pyridoindole derivative. Life Sci., 1999, 65, 1879-1881.
61. Suzen, S.; Bozkaya, P.; Coban, T.; Nebioglu, D. Investigation of the in vitro antioxidant behaviour of some 2-phenylindole derivatives: discussion on possible antioxidant mechanisms and comparison with melatonin. J. Enzym Inhib. Med. Chem., 2006, 21, 405-411.
62. Ates-Alagoz, Z.; Coban, T.; Suzen, S. A Comparative study: evaluation of antioxidant activity of melatonin and some indole derivatives. Med. Chem. Res., 2005, 14, 169-179.
63. Yilmaz A.D.; Coban, T.; Suzen, S. Synthesis and antioxidant activity evaluations of melatonin-based analogue indolehydrazide/ hydrazone derivatives. J. Enz. Inhib. Med. Chem. , 2012, 27, 428-436
64. Gurkok, G.; Coban, T.; Suzen, S. Melatonin analogue new indole hydrazide/hydrazone derivatives with antioxidant behavior: synthesis and structure-activity relationships. J. Enzym Inhib. Med. Chem., 2009, 24, 506-515.
65. Shirinzadeh, H.; Eren, B.; Gurer-Orhan, H.; Suzen, S.; Ozden, S. Novel indole-based analogs of melatonin: synthesis and in vitro antioxidant activity studies. Molecules, 2010, 15, 2187-2202.
66. Suzen, S.; Demircigil, T.; Buyukbingol, E.; Ozkan, S.A. Electroanalitical Evaluation and Determination of 5-(3'-indolyl)-2-thiohydantoin Derivatives by Voltammetric studies: possible relevance to in vitro metabolism. New J. Chem., 2003, 27, 1007-1011.
67. Suzen, S.; Ate-Alagoz, Z.; Demircigil, T.; Ozkan, S.A. Synthesis and Analytical Evaluation by Voltammetric Studies of Some New Indole-3-propionic acid Derivatives. Farmaco, 2001, 56, 835-840.
68. Shirinzadeh, H.; Yilmaz, A.D.; Gumustas, M.; Suzen, S.; Ozden, S.; Ozkan, S.A. Electrochemical behavior of indole-3-carboxaldehyde izonicotinoyl hydrazones: discussion on possible biological behavior. Chem. High. T. Synt ., 2010, 13, 619-627.
69. Reiter RJ. Cytoprotective properties of melatonin: Presumed association with oxidative damage and aging. Nutrition, 1998, 14, 691-696.
70. Das-Evcimen, N.; Yildirim, O.; Suzen, S. Relationship between aldose reductase and superoxide dismutase inhibition capacities of indole-based analogs of melatonin derivatives. Arch. Biol. Sci. Belgrade, 2009, 61, 675-681.
71. Suzen, S.; Das-Evcimen, N.; Varol, P.; Sarikaya, M. Preliminary evaluation of rat kidney aldose reductase inhibitory activity of 2-phenylindole derivatives: affiliation to antioxidant activity. Med. Chem. Res., 2007, 16, 112-118.
72. Suzen, .S.; Buyukbingol, E. Recent Studies of Aldose Reductase Enzyme Inhibition for Diabetic Complications. Current Med. Chem., 2003, 10, 1329-1352.
73. Biradar, J.S.; Sasidhar, B.S.; Parveen, R. Synthesis, antioxidant and DNA cleavage activities of novel indole derivatives. Eur. J. Med. Chem., 2010, 45, 4074-8.
74. Taj, T.; Kamble, R.R.; Gireesh, T.M.; Hunnur, R.K.; Margankop, S.B. One-pot synthesis of pyrazoline derivatised carbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities. Eur. J. Med. Chem., 2011, 46, 4366-73.
75. Lakshmi, N.V.; Thirumurugan, P.; Noorulla, K.M.; Perumal, P.T. InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives. Bioorg. Med. Chem. Lett., 2010, 20, 5054-61.
76. Debra, C.Q.; Kathy, A.K.; Kern, E.R. In vitro and in vivo evaluation of isatin-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Res., 2006, 71, 24-30.
77. Karali, N.; Gürsoy, A.; Kandemirli, F.; Shvets, N.; Kaynak, F.B.; Ozbey, S.; Kovalishyn, V.; Dimoglo, A. Synthesis and structureantituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg. Med. Chem., 2007, 15, 5888-5904.
78. Raja, S.V.; Changkun, H.; Hoyun, L. Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their antibreast cancer activity. Bioorg. Med. Chem., 2009, 17, 7585-7589.
79. Gudipati, R.; Anreddy, R.N.; Manda, S. Synthesis, anticancer and antioxidant activities of some novel N-(benzo[d]oxazol-2-yl)-2-(7-or 5-substituted-2-oxoindolin-3-ylidene) hydrazinecarboxamide derivatives. J. Enzyme Inhib. Med. Chem., 2011, 26, 813-8.
80. Khaledi, H.; Alhadi, A.A.; Yehye, W.A.; Ali, H.M.; Abdulla, M.A.; Hassandarvish, P. Antioxidant, cytotoxic activities, and structure-activity relationship of gallic acid-based indole derivatives. Arch. Pharm. (Weinheim), 2011,344, 703-9.
81. Ghorab, M.M.; Ragab, F.A.; Noaman, E.; Heiba, H.I.; El-Hossary, E.M. Synthesis of some novel quinolines and pyrimido [4,5-b] quinolines bearing A sulfonamide moiety as potential anticancer and radioprotective agents. Arzneimittelforschung, 2007, 57, 795-803.
82. Shirole, N.L.; Talele, G.S.; Fursule, R.A.; Surana, S.J.; Jain, K.S. Synthesis, and ... of Novel 2-Alkylamino and 2-Dialkylaminomethylthieno[2,3-d] pyrimidines. Asian J. Chem., 2006, 18, 2673-2679.
83. Rashad, A.E.; Shamroukh, A.H.; Hegab, M.I.; Awad, H.M. Synthesis of some biologically active pyrazoles and C-nucleosides. Acta Chim. Slov., 2005, 52, 429-434.
84. Shahabuddin, M.S.; Gopal, M.; Raghavan, S.C. J. Intercalating and antitumour activity of 4-Oxopyrimido[40, 50:4, 5]thieno(2,3-b)quinoline-4(3H)- one. Cancer Mol., 2007, 3, 139-146.
85. Aly, A.A.; Brown, A.B.; Ramadan, M.; Gamal-Eldeen, A.M.; Abdel-Aziz, M.; Abuo-Rahma, Gel-D.; Radwan, M.F. Thieno[2,3-d]pyrimidines in the synthesis of antitumor and antioxidant agents. Arch. Pharm., (Weinheim). 2010, 343, 301-9.
86. Fadda, A.A.; Hammoda, M.; Afsah, E.A.; Hanash, A.A. Nitriles in Organic Synthesis: Synthesis of New Benzothiazole Derivatives of Biological Interest. Phosphorous Sulfur Silicon Relat Elem., 2010, 185, 433-446.
87. Fadda, A.A.; Berghot, M.A.; Amer, F.A.; Badawy, D.S.; Bayoumy, N.M. Synthesis and Antioxidant and Antitumor Activity of Novel Pyridine, Chromene, Thiophene and Thiazole Derivatives. Arch. Pharm. Chem. Life Sci., 2012, 345, 378-385.
88. Liou, G.Y.; Storz, P. Reactive oxygen species in cancer. Free Rad. Res., 2010, 44, 479-496.
89. Lowenfels, A.B.; Maisonneuve, P.; Cavallini, G.; Ammann, R.W.; Lankisch, P.G.; Andersen, J.R. International Pancreatitis Study Group et al. Pancreatitis and the risk of pancreatic cancer. Pancreatitis study group. N. Engl. J. Med., 1993, 328, 1433-1437
90. Conklin, K.A. Cancer chemotherapy and antioxidants. J. Nutr., 2004, 134, S3201-S3204
91. Conklin, K.A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr. Cancer Ther., 2004, 3, 294-300